Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients

AIDS

Volumn 14, Issue 5, 2000, Pages 517-524

  Anduze Faris, Béatrice M ^a   Fillet, Anne Marie ^a   Gozlan, Joël ^b   Lancar, Rémi ^b   Boukli, Narjis ^b   Gasnault, Jacques ^c   Caumes, Eric ^a   Livartowsky, Joël ^d   Matheron, Sophie ^e   Leport, Catherine ^e   Salmon, Dominique ^f   Costagliola, Dominique ^b   Katlama, Christine ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c BICÊTRE HOSPITAL   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

^e BICHAT HOSPITAL   (France)

^f Hôpital Cochin ^*  (France)

Author keywords

Central nervous system; Cytomegalovirus; Encephalitis; Foscarnet; Ganciclovir; HIV; Myelitis

Indexed keywords

ANTIRETROVIRUS AGENT; FOSCARNET; GANCICLOVIR; PROTEINASE INHIBITOR;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENCEPHALITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MULTICENTER STUDY; MYELITIS; PRIORITY JOURNAL; RELAPSE; SIDE EFFECT; SURVIVAL TIME;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; ENCEPHALITIS, VIRAL; FEMALE; FOSCARNET; GANCICLOVIR; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; SURVIVAL RATE;

EID: 0034085104     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200003310-00007     Document Type: Article

References (39)

1. 1. McCutchan JA. Cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 1995, 20:747-754.
2. 2. Fuller GN. Cytomegalovirus and the peripheral nervous system in AIDS. J Acquired Immune Defic Syndr 1992, 5 (Suppl. 1):S33-S36.
3. 3. Roullet E, Assuerus V, Gozlan J, et al. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases. Neurology 1994, 44:2174-2182.
4. 4. Morgello S, Cho ES, Nielsen S, Devinsky O, Petito CK. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Hum Pathol 1987, 18:289-297.
5. 5. Wilkes MS, Fortin AH, Felix JC, Godwin TA, Thompson WG. Value of necropsy in acquired immunodeficiency syndrome. Lancet 1988, 8602:85-88.
6. 6. Fillet AM, Katlama C, Visse B, Camilleri S, Rogeaux O, Huraux JM. Human CMV infection of the CNS: concordance between PCR detection in cerebrospinal fluid and pathological examination [Letter]. AIDS 1993, 7:1017-1018.
7. 7. Gozlan J, El Amrani M, Baudrimont M, et al. A prospective evaluation of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of cytomegalovirus-related neurological diseases during AIDS. AIDS 1995, 9: 253-260.
8. 8. Mastroianni CM, Ciardi M, Folgori F, et al. Cytomegalovirus encephalitis in two patients with AIDS receiving ganciclovir for Cytomegalovirus retinitis. J Infect 1994, 29:331-337.
9. 9. Mussini C, Mongiardo N, Manicardi G, et al. Relevance of clinical and laboratory findings in the diagnosis of Cytomegalovirus encephalitis in patients with AIDS. Eur Clin Microbiol Infect Dis 1997, 16:437-444.
10. 10. Holland NR, Power C, Mathews VP, Glass JD, Forman M, McArthur JC. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Neurology 1994, 44:507-514.
11. 11. Weinberg DV, Murphy R, Naughton K. Combined daily therapy with intravenous ganciclovir and foscarnet for patients with recurrent cytomegalovirus retinitis. Am J Ophthalmol 1994, 117:776-782.
12. 12. Hengge UR, Brockmeyer NH, Malessa R, Ravens U, Goos M. Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis. Antimicrob Agents Chemother 1993, 37:1010-1014.
13. 13. Fletcher C, Sawchuk R, Chinnock B, de Miranda P, Balfour HH. Human pharmacokinetics of the antiviral drug DHPC. Clin Pharmacol Ther 1986, 40:281-286.
14. 14. Manischewitz JF, Quinnan GV, Lane HC, Wittek AE. Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro. Antimicrob Agents Chemother 1990, 34:373-375.
15. 15. Gozlan J, Salord JM, Roullet E, et al. Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J Infect Dis 1992, 166:1416-1421.
16. 16. Wolf DG, Spector SA. Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. J Infect Dis 1992, 166:1412-1415.
17. 17. Demmler G, Buffone GJ, Scimbor CM, May RA. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis 1988, 158: 1177-1184.
18. 18. Kim YS, Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 1993, 17:32-37.
19. 19. Cohen BA, McArthur JC, Grohman S, Patterson B, Glass J. Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS. Neurology 1993, 43:493-499.
20. 20. Karmochkine M, Molina JM, Scieux C, et al. Combined therapy with ganciclovir and foscarnet for cytomegalovirus polyradiculomyelitisin patients with AIDS. Am J Med 1994, 97:196-197.
21. 21. Peters M, Timm U, Schürmann D, Pohle HD, Ruf B. Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone: a case report and review of the literature. Clin Invest 1992, 70: 456-458.
22. 22. Price TA, Digioia RA, Simon GL. Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus. Clin Infect Dis 1992, 15:606-608.
23. 23. Enting R, De Gans J, Reiss P, Jansen C, Portegies P. Ganciclovir/ foscarnet for cytomegalovirus meningoencephalitis in AIDS [Letter]. Lancet 1992, 340:559-560.
24. 24. Peters M, Schürmann D, Pohle H, Ruf B, Timm H. Combined and alternating ganciclovir/foscarnet in HIV-related cytomegalovirus encephalitis [Letter]. Lancet 1992, 340:8825.
25. 25. Jacobson MA, Mills J, Rush J, et al. Failure of antiviral therapy for AIDS-related cytomegalovirus myelitis. Arch Neurol 1988, 45:1090-1092.
26. 26. Cinque P, Baldanti F, Vago L, et al. Ganciclovir therapy for cytomegalovirus infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. J Infect Dis 1995, 171:1603-1606.
27. 27. Miller RG, Storey JR, Greco CM. Ganciclovir in treatment of progressive AIDS-related polyradiculopathy. Neurology 1990, 40:569-574.
28. 28. Cohen BA. Prognostic and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS. Neurology 1996, 46:444-450.
29. 29. De Gans J, Portegies P, Tiessens G, Troost D, Danner SA, Lange JMA. Therapy for cytomegalovirus polyradiculomyelitis in patients with AIDS: treatment with ganciclovir. AIDS 1990, 4:421-425.
30. 30. So YT, Olney RK. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol 1994, 35:53-58.
31. 31. Arribas JR, Clifford DB, Fichtenbaum CJ, Commins DL, Powderly WG, Storch GA. Level of cytomegalovirus DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis 1995, 172:527-531.
32. 32. Shinkai M, Spectror SA. Quantitation of human cytomegalovirus DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. Scand J Infect Dis 1995, 27:559-561.
33. 33. Flood J, Drew WL, Miner R, et al. Diagnosis of cytomegalovirus polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays. J Infect Dis 1997, 176: 348-352.
34. 34. Masur H, Whitcup SM, Cartwritht C, Polis M, Nussenblatt R. Advances in the management of AIDS-related cytomegalovirus retinitis. Ann Intern Med 1996, 125:126-136.
35. 35. Arribas JR, Storch GA, Clifford DB, Tselis AC. Cytomegalovirus encephalitis. Ann Intern Med 1996, 125:577-587.
36. 36. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338:853-860.
37. 37. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
38. 38. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998, 351:1682-1686.
39. 39. Salmon-Ceron D, Mazeron MC, Chaput S, et al. Evolution of CMV blood markers in HIV-infected patients receiving protease inhibitor (ANRS PREDIVIR cohort). 5th Conference on Retroviruses and Opportunistic Infections. Chicago, February 1998 [Abstract 752].